ICON-9: A phase 3 randomised trial of cediranib and olaparib maintenance in patients with relapsed platinum sensitive ovarian cancer

Project Member(s): Viney, R., De Abreu Lourenco, R., Vargas Parada, C.

Funding or Partner Organisation: Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)
Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)

Start year: 2018

FOR Codes: Health economics , Health Economics, Evaluation of Health Outcomes, Health Policy Economic Outcomes, Evaluation of health and support services not elsewhere classified, Health policy evaluation

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.